Titan Medical Inc. is a publicly-held medical device company headquartered in Toronto, Ontario, with shares listed on the Toronto Stock Exchange (TMD) and Nasdaq (TMDI). Titan is focused on the design and development of surgical technologies for application in robotic single access surgery. Design and development activities are directed and performed by the company’s wholly owned U.S. subsidiary, Titan Medical USA Inc. based in Chapel Hill, North Carolina. The Enos™ surgical system, by Titan Medical, is being developed to become the new standard of care in robotic single access surgery with dual 3D and 2D high-definition vision systems, multi-articulating instruments, and an ergonomic surgeon workstation. With the Enos system, Titan intends to initially pursue gynecologic surgical indications. The Enos system is designed with the goals of improving clinical performance, ease of use, operating room efficiency and hospital economics. Certain of Titan’s robotic assisted surgical technologies and related intellectual property have been licensed to Medtronic plc, while retaining world-wide rights to commercialize the technologies for use with the Enos system.